STOP HIV/AIDS Rolando Barrios, MD, FRCPC Assistant Director BC Centre for Excellence in HIV/AIDS Assistant Medical Director HIV/AIDS Program Providence.

Slides:

Advertisements

Similar presentations

Delphine Sculier, MD,MPH Stop TB Department World Health Organisation Geneva, Switzerland Update on the revision of ART guidelines for TB patients.

Advertisements

Slide 1 of 42 IAS–USA Treatment as Prevention: Evaluating the Impact of HAART Expansion The British Columbia (BC) Experience AU EDITED FINAL:

WFP’s Urban HIV/AIDS Nutritional Support Program in Ethiopia A joint program of USAID/Ethiopia – FFP, PEPFAR, and WFP Michelle Jennings USAID/Ethiopia.

Socially constructed exclusion: Understanding and mitigating the pervasive influences of HIV-related stigma John de Wit, Professor and Director Centre.

Cascade The Continuum of HIV Care Florida, 2013 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2013, as of 06/30/2014.

HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.

“Getting to Zero: Thailand’s Experience with E-MTCT” Petchsri Sirinirund Advisor on HIV/AIDS Policy and Programme Department of Disease Control, Thailand.

HIV Partner Notification in the U.S.: A National Survey of Program Coverage and Outcomes Matthew Golden MD, MPH Assistant Professor of Medicine, UW Medical.

Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.

Role of Optical Shops and Pharmacies In Financial Sustainability of OE Partner Hospitals Dr. Santosh Moses Assistant Director – Eye Health.

HIV in Suriname Ministry of Health Suriname M.Sigrid Mac Donald – Ottevanger, MD Focal point HIV Treatment and Care, NAP.

The effects of OAT and HAART on the cause-specific risk of mortality among HIV positive people who inject drugs Bohdan Nosyk, PhD Associate Professor,

ARIES Users Group Training Webinar Presented by California Department of Public Health Office of AIDS —Karl Halfman, Health Program Specialist Program.

PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV WHAT’S NEW Prepared by Dr. Debbie Carrington National HIV/AIDS Prevention & Control Programme Ministry.

Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.

Health Care Reform Through the Cancer Lens State and Private Sector Reforms for Hispanic Healthcare Edward E. Partridge, MD National Board President American.

Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.

Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.

HIV Treatment and Care Research priorities Facilitator – Dr Saphonn Vonthanak 12 participants 29 agreed topics –not grouped on methodology or subject category.

Botswana National Program: Nurses Dispensing ARVs Tendani Gaolathe M.D Director Botswana-Harvard Partnership /PEPFAR Master Trainer Program.

A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,

Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.

eHARS to CAREWare Pilot Project Update and Training

1 Diagnosis of HIV Infection in Children HAIVN Harvard Medical School AIDS Initiatives in Vietnam.

Slide 1 of 42 IAS–USA AU EDITED FINAL: Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director,

HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.

Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.

A Qualitative Investigation of Patients’ Transitional States of Engagement in HIV-Related Medical Care Stephanie Koch, MS, Mary Gerkovich, PhD, Karen Williams,

Antiretroviral Treatment Monitoring: A Canadian Case Example Antiretroviral Treatment Monitoring: A Canadian Case Example Robert Hogg, PhD BC Centre for.

NURSETRI, Nursing role in HIV care : an overview Jane Bruton Clinical Research Nurse.

British Columbia Centre for Excellence in HIV/AIDS Julio Montaner MD, FRCPC, FCCP, FRSC Director, BC-Centre for Excellence on HIV/AIDS, Providence Health.

I. Jean Davis, PhD, PA, AAHIVS Manager - Clinical Services Desert AIDS Project.

Immigration Removal Centres and HIV Clinical Care Jane Anderson Homerton University Hospital NHS Foundation Trust.

The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.

Evaluating the Use of HIV Surveillance Data for Initiating Partner Services in Houston, Texas, US 2012 International AIDS Conference Washington, D.C. Shirley.

Philippe Chiliade, MD, MHA Technical Advisor, Clinical Care, FHI 12 August 2008 Family Health International Implementing HIV Care & Treatment Progress.

HIV/AIDS Track Session. Key Points Application of international reference price list during a national tender is a valuable tool for achieving optimal.

HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.

Potential Utility of Tipranavir in Current Clinical Practice Daniel R. Kuritzkes, MD Director of AIDS Research Brigham and Woman’s Hospital Division of.

JORDAN E. LAKE, MD, MSC AAHU AUGUST 2015 Prevention for Positives.

1 HIV/STD in Texas Ann Robbins Texas Department of State Health Services June 2009.

From operational research to policy and practice The Union, Paris, France MSF, Brussels, Belgium.

Getting to Zero: Will San Francisco be the first city to succeed? Diane Havlir, MD, Professor of Medicine, UCSF, Chief HIV San Francisco General Hospital.

KEY ISSUES FACING LATINO COMMUNITY IN ADDRESSING HIV/AIDS AN OVERVIEW.

Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,

Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.

The HIV Care Continuum: A Tool for Driving Systematic Change to Support Better Engagement in Care Jeffrey S. Crowley Distinguished Scholar/ Program Director.

1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.

Methadone Maintenance System Performance Measures – 2011/2012 Office of the Provincial Health Officer January 28, Dr. Eric Young, MD, MHSc, CCFP,

N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Major Changes to the HHS Adult and Adolescent HIV Treatment Guidelines: April 2015 Brian R. Wood, MD.

Organizing Drug Users for Public Health Policy Changes 17 th International Conference on the Reduction of Drug Related Harm Jason Farrell, Executive Director.

Acute Health Care Perspectives on Homelessness Research Making Data Meaningful April 23, 2015 Ginetta Salvalaggio, MSc, MD, CCFP Assistant Professor, University.

Estimating the population impact of homelessness on HIV viral suppression among people who use drugs Brandon DL Marshall, 1 Beth Elson, 1 Sabina Dobrer,

Ryan White Part A Program Update Health & Family Services Department Presentation to the Board of County Commissioners June 12, 2007.

TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.

Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.

Vancouver, British Columbia, Canada

XIVV International AIDS Conference, Mexico City 3-8 August 2008

Amanda D. Castel, MD, MPH Assistant Research Professor

The Debswana Anti Retroviral Therapy Programme

Substance Use Disorders in People Living with HIV

AGEISM “A process of systematic stereotyping of and

Documenting barriers to access HCV care and treatment: a peer-led research João Santa Maria, Magda Ferreira, Renato Pinto, Joana Sanches, Álvaro Ávila,

Professor of Clinical Psychiatry

Dr. Velephi Okello, Principal Investigator, MaxART Trial

What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?

An Update from CROI and the Changing Landscape of HIV in NZ

The HIV Epidemic among People who Inject Drugs

Adults with Health Problems Who Have an Excellent Patient Experience Report Greater Support to Help Manage Their Health Condition Percent of adults 18–64.

Collaborative TB/HIV activities in European Region

Presentation transcript:

STOP HIV/AIDS Rolando Barrios, MD, FRCPC Assistant Director BC Centre for Excellence in HIV/AIDS Assistant Medical Director HIV/AIDS Program Providence Health Care Adjunct Professor – School of Population and Public Health, UBC

Background: Natural History of HIV is well known. The importance of early HIV diagnosing and its impact on transmission and outcomes. The importance of timely access to care, and support. The role of ARV treatment both at individual and population level. Increase understanding of HIV as a chronic manageable condition requiring greater involvement from patients (self-management)

HOW HIV affects BC 1:4 people infected with HIV are unaware of their HIV positive status. They won’t benefit from care and treatment They contribute to ~ 60% of new infections 1:3 people dying from HIV in BC have never accessed ARV treatment. Higher HIV rates among particular groups Higher mortality rates in some geographic areas

STOP HIV/AIDS Business case for the need to expand HIV care and treatment was prepared Government decided to implement a Pilot Project in the two most affected areas Vancouver’s inner city Downtown Prince George Funded provided to VCH, NH, PHSA, BCCFE and PHC. Development of strategic goals and a model for monitoring and evaluation was developed

Indicators #IndicatorProvincialVancouverNorthern Interior 7HCV & HIV Testing50%62%65% 9Advanced HIV at Diagnosis14%13%<1% 11Acute Infection6%9%6% 14Late ARV initiation29%24%<1% 21DRT before ARV start84% 100% 22Suppressed pVL on ART61%64%57% 23Appropriate ART combination 81% 100% 24Rx refill adherence73%76%46% 25# MDs initiating ARV Rx ARV regimen change %0% STOP HIV/AIDS Pilot Project – Indicators Report (August 2010)

LISA Survey VCHNHALISA Unstable housing*37%29%32% Receiving Income Assistance75%85% Food insecure70%86%66% Unemployment78%67% Not satisfied with physician5%14%6% LISA Participants: N= % from NHA and 67% from VCH 26% Women, 81% use HIV-related programs and services regularly *Unstable housing defined as living in a hotel, boarding room, hostel, transition house, prison, hospital or not having a fixed address at the time of the interview Hogg et al (Summary statistics of the LISA Project)

Questions? Contact: Rolando Barrios: